scholarly journals 161. Analysis of Target Site Selection for the Sleeping Beauty Transposon in Mouse Liver

2003 ◽  
Vol 7 (5) ◽  
pp. S63
2000 ◽  
Vol 66 (1) ◽  
pp. 87-100 ◽  
Author(s):  
Michael Katzman ◽  
Malgorzata Sudol ◽  
Jeffrey S. Pufnock ◽  
Shawn Zeto ◽  
Lynn M. Skinner

10.1038/8658 ◽  
1999 ◽  
Vol 17 (5) ◽  
pp. 480-486 ◽  
Author(s):  
Murray J. Cairns ◽  
Toni M. Hopkins ◽  
Craig Witherington ◽  
Li Wang ◽  
Lun-Quan Sun

Tumor Biology ◽  
2011 ◽  
Vol 32 (4) ◽  
pp. 809-817 ◽  
Author(s):  
YaoFei Wang ◽  
JingNan Shen ◽  
XiFu Shang ◽  
Jin Wang ◽  
JingChun Li ◽  
...  

2002 ◽  
Vol 323 (3) ◽  
pp. 441-452 ◽  
Author(s):  
Thomas J. Vigdal ◽  
Christopher D. Kaufman ◽  
Zsuzsanna Izsvák ◽  
Daniel F. Voytas ◽  
Zoltán Ivics

2019 ◽  
Author(s):  
Yiting Zhou ◽  
Guangwei Ma ◽  
Jiawen Yang ◽  
Yabin Guo

Abstract Background: Sleeping Beauty (SB) transposon had been thought to strictly integrate into TA dinucleotides. Recently, we found that SB also integrates into non-TA sites at a lower frequency. Here we performed further study on the non-TA integration of SB. Results: 1) SB can integrate into non-TA sites in HEK293T cells as well as in mouse cell lines. 2) Both the hyperactive transposase SB100X and the traditional SB11 catalyze integrations at non-TA sites. 3) The consensus sequence of the non-TA target sites only occur at the opposite side of the sequenced junction between transposon end and the genomic sequences, indicating that the integrations at non-TA sites are mainly aberrant integrations. 4) The consensus sequence of the non-TA target sites is corresponding to the transposon end sequence. When the transposon end sequence is mutated, the consensus sequences changed too. Conclusion: The interaction between the SB transposon end and genomic DNA may be involved in the target site selection of the SB integrations at non-TA sites.


Sign in / Sign up

Export Citation Format

Share Document